Skip to content
Screener

Organogenesis Holdings Inc. ORGO Q1 2025 Annual earnings

Reported May 8, 2025 · After market close

Revenue$86.7MMiss by $4.1M
EPS-$0.13Miss by $0.17
Revenue estimate$90.8M
EPS estimate$0.04

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$52.1M
EPS estimate-$0.18

Financials

Q1 2025

Income statement

See full
Revenue$86.7M-21.2%
Gross profit$63.0M-22.5%
Operating income-$26.7M-594%
Net income-$18.8M-797%
EPS (diluted)-$0.17-750%

Balance sheet

See full
Cash & equivalents$110.0M+24.1%
Total debt$31.6M-70.4%
Total equity$242.9M-12.6%
Total assets$467.4M+1.9%

Cash flow

See full
Operating cash flow-$19.9M-96.2%
CapEx$3.6M+63.2%
Free cash flow-$23.6M-90.3%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$547.9M+47.4%
Enterprise value$469.51M+20.5%
P/S1.2×+0.3×

Profitability

See full
Gross margin75.9%+0.8pp
Net margin-3.5%—

Returns & leverage

See full
Return on equity-6.1%—
Debt / equity0.1×-0.3×
Current ratio4.1×+1.4×

FAQ

When did Organogenesis Holdings Inc. report Q1 2025 earnings?
Organogenesis Holdings Inc. (ORGO) reported Q1 2025 earnings on May 8, 2025 after market close.
What were Organogenesis Holdings Inc.'s Q1 2025 revenue and EPS?
Organogenesis Holdings Inc. reported revenue of $86.7M and eps of $-0.13 for Q1 2025.
Did Organogenesis Holdings Inc. beat estimates in Q1 2025?
Revenue missed the consensus estimate of $90.8M by $4.1M. EPS missed the consensus estimate of $0.04 by $0.17.
How did Organogenesis Holdings Inc.'s Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 21.2% from $110.0M a year earlier and eps declined 550.0% from $-0.02.
Where can I find Organogenesis Holdings Inc.'s Q1 2025 SEC filings?
You can read the 8-K earnings release (0000950170-25-066930) and the 10-K/A periodic report (0001193125-25-104050) directly on SEC EDGAR. The filing index links above go to sec.gov.